Patents Assigned to Dainippon Sumitomo Pharma Company, Limited
  • HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDES
    Publication number: 20090099090
    Abstract: HLA-A24-restricted peptides derived from WT1 which have an activity to induce CTLs in vivo, polynucleotides encoding said peptides, cancer vaccines using those peptides or polynucleotides in vivo or in vitro, or the like are provided. The cancer vaccines of the present invention may be used to treat many cancer patients.
    Type: Application
    Filed: June 19, 2008
    Publication date: April 16, 2009
    Applicants: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED, CHUGAI SEIYAKU KABUSHIKI KAISHA, International Institute of Cancer Immunology, Inc, Dainippon Sumitomo Pharma Company, Limited
    Inventors: Haruo Sugiyama, Masashi Gotoh, Hideo Takasu